Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Performance of Diagnostic Contrast-enhanced Mammography and Magnetic Resonance Imaging for Suspicious Breast Lesion at Screening

NCT05390229 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT05390229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05390229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Performance of Diagnostic Contrast-enhanced Mammography and Magnetic Resonance Imaging for Suspicious Breast Lesion at Screening
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Observational
Overall status
Completed
Start date
December 12, 2018
Completion date
December 31, 2025
Enrollment
231 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer